JOSEPH HAKES: Open Payments
NPI 1407000714 · FARMINGTON, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$318 in 16 payments from 8 companies in 2025. Trend: 2023 $539 · 2024 $487 · 2025 $318
Food & beverage: $318
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $83 |
| PFIZER INC. | 3 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Insulet Corporation | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $42 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
Products named: JARDIANCE, Omnipod, XIFAXAN, QULIPTA, NURTEC ODT, VRAYLAR, UBRELVY, BREZTRI.
Industry payments across NM — which companies pay providers there.
